Nike CEO Elliott Hill started as an intern in 1988 before climbing the corporate ladder to CEO after more than 30 years. In an exclusive interview with Fortune, Hill shared his vision for the iconic ...

A physician would insert a needle into the senator's arm at the clinic, and then, for about two hours a solution would drip ...

Mall REITs Simon and Brookfield acquired J.C. Penney about four years ago, and Authentic later also took a stake. Marc Rosen, formerly J.C. Penney’s CEO, is now CEO of Catalyst Brands ...

Oklahoma State's Barry Sanders is the all-time single-season rushing leader with 2628 yards in his 1988 Heisman-winning season. Sanders is one of six of the top 30 single-season rushing leaders to ...

The J.C. Penney Corp. Inc.-Bond has a maturity date of 7/1/2023 and offers a coupon of 5.8750%. The payment of the coupon will take place 2.0 times per biannual on the 01.01.. The J.C. Penney Corp ...

The original subway vigilante, Bernie Goetz, thinks the prosecution of Daniel Penny for the chokehold death of Jordan Neely aboard a train was “BS.” Goetz, 77, spoke to WABC’s Frank Morano ...

The former Oklahoma State star running back's 222 yards in the Holiday Bowl do not count toward his 1988 rushing record.

Penny stocks have always been interesting to more seasoned investors looking to make big gains with minimal upfront investment. These low-priced stocks, typically trading below $5 per share, are ...

On Dec. 21, 1988, a bomb exploded on Pan Am Flight 103 over Lockerbie, Scotland, traveling from London to New York, breaking it apart and sending it to Earth. Flora Swire, a 23-year-old ...

In this article, we will look at the 12 Best Long-Term Penny Stocks to Buy According to Hedge Funds. What’s the Future Like for Small Cap Stocks in 2025? On December 3rd, Bob Kaynor, CFA ...

The geopolitical thriller is rooted in the chilling true events of 1988. Here's all you need to know about one of history's most devastating air disasters. On December 21, 1988, a mere 38 minutes ...

Overview: Equillium, Inc. is a clinical-stage biotechnology company focused on developing and selling products for severe autoimmune and immuno-inflammatory disorders with unmet medical needs ...